BSECompany Update24 Aug 2026 · 24 Aug 2026, 03:08 pm

Akums Drugs and Pharmaceuticals Limited has informed the exchange about an update on schedule of the Investors/ Analysts Meet to be held on August 25, 2026

Akums Drugs and Pharmaceuticals Ltd · 544222

✦ AI SummaryMgmt Change

Akums Drugs and Pharmaceuticals Ltd has cancelled its participation in an Investors/Analysts Meet on August 25, 2026, due to medical reasons.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Akums Drugs and Pharmaceuticals Ltd - 544222 - Update On Schedule Of The Investors/Analysts Meet To Be Held On August 25, 2026

Attachments (1)

📄

73dea697-4bca-4319-a4e5-a1383764767f.pdf

pdf

Download →
View document text
Ref: Akums/Exchange/2026-27/46 August 24, 2026 To, To, The Listing Department The Listing Department National Stock Exchange of India Ltd BSE Limited Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring, Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001 Symbol: AKUMS Scrip Code: 544222 Sub: Update on Schedule of the Investors/Analysts Meet to be held on August 25, 2026 Respected Sir/Ma’am, With reference to our earlier intimation bearing reference no. Akums/Exchange/2026-27/45 dated August 13, 2026, we wish to inform you that the concerned personnel of Akums Drugs and Pharmaceuticals Limited (the “Company”) will not be able to participate in the Investor/Analysts Meet being organized by Antique Stock Broking Limited on August 25, 2026, at Trident, Bandra Kurla Complex, Mumbai, due to medical reasons. Accordingly, the participation of the Company in the said event stands cancelled. This is for your information and records. Thanking You Yours Faithfully For Akums Drugs and Pharmaceuticals Limited Dharamvir Malik Company Secretary & Compliance Officer